Table 2 ISAR-STEREO trial outcome
From: Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
Group | Strut thickness ( µm) | Mortality rate (%) | MI (%) | Restenosis (%) | Reference |
|---|---|---|---|---|---|
Thin Strut (n = 325) | 50 | 1.5 | 0.9 | 15 | [23] |
Thick Strut (n = 325) | 140 | 2.5 | 1.2 | 25 |